Ecolab (ECL) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 reported sales rose 13% to $4.695B; organic sales grew 7%, with volume up 2% and pricing up 5%.
Adjusted operating income increased 14%; organic operating income grew 11%. Adjusted diluted EPS rose 5% to $2.18, including a ~10% CoolIT-related amortization and financing headwind.
Growth engines accelerated, led by 63% organic growth in Global High-Tech; growth also strengthened in Life Sciences, Digital, and Pest.
Integrated water, hygiene, pest, and digital offerings supported customer wins; One Ecolab generated over $400M in sales growth with its 35 largest customers.
Financial highlights
Q3 net sales were $4,694.8M versus $4,165.0M; adjusted operating income was $893.4M, up 14%, and reported operating income was $810.5M, up 7%.
Reported net income was $551.3M versus $585.0M; adjusted net income was $615.4M versus $590.7M.
Reported diluted EPS was $1.95 versus $2.05; adjusted diluted EPS was $2.18 versus $2.07.
Digital sales grew 34% to $129M, with growth in hardware subscriptions and software.
Outlook and guidance
FY2026 adjusted diluted EPS guidance is $8.10–$8.20, growth of 8%–9%, including a ~6-point CoolIT-related headwind.
Q4 reported sales growth is expected at 12%–14%, organic sales growth at 6%–7%, and adjusted diluted EPS at $2.13–$2.23, up 2%–7%.
Q4 adjusted operating margin is expected at ~19% and organic operating margin at ~20%; CoolIT-related costs are expected to create a ~12-point EPS headwind.
For 2027, organic sales growth is expected at the upper end of the 5%–7% target and adjusted operating income margin at 20%; underlying earnings growth is expected in the mid-teens, with transaction effects shifting from a 5-point H1 headwind to a 5-point H2 tailwind.
2027 top-line assumptions include 1%–2% pricing and volume growth; volume is expected to rise from 1%–2% in H1 to 2%–3% in H2 as pricing moderates.
Latest events from Ecolab
- Pricing and reopening-driven growth lifted Q2 earnings despite higher costs and freeze impacts.ECL
Q2 2021 - Double-digit EPS growth and raised 2026 outlook, driven by strong sales and acquisitions.ECL
Q2 2026 - Strong growth, high margins, and innovation drive robust financial and shareholder returns.ECL
Investor presentation - Growth engines, innovation, and acquisitions drive strong sales, margin expansion, and returns.ECL
46th Annual William Blair Growth Stock Conference - Board elections, record financials, and AI-driven growth strategy highlighted; governance proposal rejected.ECL
AGM 2026 - Double-digit adjusted EPS and sales growth, with strong 2026 outlook and major acquisitions.ECL
Q1 2026 - 2026 outlook projects double-digit EPS growth, margin expansion, and strong organic sales.ECL
Q4 2025 - Q3 organic sales up 4%, adjusted EPS up 19%, and guidance raised 27–29% for the year.ECL
Q3 2024 - Record sales, margin gains, and double-digit 2025 EPS growth expected despite FX headwinds.ECL
Q4 2024